Indefinite Delivery Contract 36C10G24D0038
- Not listed
- Mimedx Group, Inc. has been awarded a $67.1 million multiple-award Federal Supply Schedule contract (FSS-65-II-A) by the Department of Veterans Affairs Veterans Integrated Service Network 12, effective from March 1, 2022 through February 28, 2027. The contract establishes a framework for the procurement of medical equipment and supplies, specifically focusing on amnion-based implants and regenerative biomaterial products for wound care and surgical applications. Under this vehicle, Mimedx...
- The Department of Veterans Affairs awarded Mimedx Group, Inc. a blanket purchase agreement to supply wound care products and services in support of the Veterans Health Administration's Medical/Surgical Prime Vendor program. With a potential value of $7 million over multiple years, this IDV enables Mimedx to provide amniotic tissue allografts, wound dressings, and related solutions to VHA facilities nationwide. The originating pre-solicitation notice sought to establish blanket purchase...
- The federal contract IDV award is a single-award Indefinite Delivery Contract (IDC) awarded by the Department of Veterans Affairs (VA) to Medtronic Inc., through its Medtronic USA, Inc. division. The contract, valued at up to $600 million, is for the provision of surgical implants and related products and services to support the VA's mission of delivering quality healthcare to veterans. The IDC facilitates the VA's procurement of a wide range of Medtronic's medical devices, including spinal cord...
- The federal contract IDV award is for a Biologics and Biological Implants Multiple Award Indefinite Delivery Contract with a total potential value of $2,103,383,326.64, awarded by the Department of Veterans Affairs Headquarters to the prime contractor RTI Surgical, Inc. The contract aims to procure a range of orthopedic, spinal, and reconstructive surgical implants, hardware, instrumentation, and allograft tissue products to support surgical care for veterans and armed services members. Under...
- The Department of Veterans Affairs awarded an indefinite delivery contract to Regenerative Processing Plant LLC under the Biologics and Biological Implants multiple award IDV. The IDV has a potential value of $2.1 billion for biological implants including allografts from human cadavers and xenografts from animals to be used in VA surgeries and medical procedures. Implants must be FDA approved and tracked from source to implantation per ISBT 128 standards. Under the IDV, Regenerative Processing...
- Medtronic Inc., through its Medtronic USA, Inc. division, was awarded a single-award Indefinite Delivery Contract (IDC) by a civilian federal agency with a ceiling value of $1.80 billion and a performance period extending through December 14, 2028. The contract, designated for "Surgical Implants Next Generation," was awarded on December 15, 2023, without set-aside provisions through full and open competition. A recent modification to the contract removed six items from option years two...
- The Department of Veterans Affairs (VA) has awarded an Indefinite Delivery Contract (IDC) with a total ceiling value of $563,246,587.24 to Medtronic USA Inc., a foreign-owned, for-profit manufacturer of medical devices and therapies. The master IDC, titled "VA Prosthetic Implants and Appliances 2016-2021", provides a vehicle for the VA's Veterans Health Administration (VHA) to procure a range of prosthetic implants, appliances, and related equipment and services to support healthcare...
- Medtronic Inc., a global medical technology company, has been awarded a $150 million Indefinite Delivery Contract (IDC) by the U.S. Department of Veterans Affairs (VA) to provide a wide range of surgical implants, medical devices, and related products and services. This IDC allows the VA to efficiently procure Medtronic's advanced medical technologies, including spinal cord stimulators, pacemakers, neurostimulators, deep brain stimulators, cardiac devices, surgical navigation systems, and...
- The Department of Veterans Affairs (VA) has awarded an Indefinite Delivery Contract (IDC) to Spartan Medical Inc., a Service-Disabled Veteran-Owned Small Business, to provide a range of biologics and biological implants for use in VA medical procedures and surgeries. The $2.1 billion, multiple-award IDC has a 1-year base period plus four 1-year options. The contracted products include allografts from human cadavers and xenografts from animals, such as various types of bone and soft tissue...
- The provided materials detail a multiple-award Indefinite Delivery Contract (IDC) awarded by the U.S. Department of Veterans Affairs (VA) to Organogenesis Inc., a leading regenerative medicine company. The contract, worth up to $2.1 billion over five years, is for the procurement of various biologics and biological implants, including allografts from human cadavers and xenografts from animals, to be used in VA medical procedures and surgeries. Organogenesis Inc. has been awarded several delivery...
- 36C10G24D0038Indefinite Delivery Contract
- 2Federal Contract Awards
The federal contract IDV awarded to Mimedx Group, Inc. is for the delivery of biologic and non-biologic prosthetic surgical implants to the U.S. Department of Veterans Affairs (VA) and Indian Health Service (IHS), civilian federal agencies. The single-award IDV has a ceiling value of $21,001,264.47 and a period of performance through November 2026. Mimedx, a for-profit manufacturer of regenerative biomaterial products, surgical implants, and advanced wound care solutions, has also been awarded delivery orders under this IDV valued at $10,380.04 for surgical implants and $2,500.00 for biologics and non-biologic prosthetics. These firm fixed-price delivery orders have ultimate completion dates in 2024 and 2025. Mimedx has existing multi-year, multi-million dollar contracts and blanket purchase agreements with the VA to facilitate the nationwide delivery of its specialized medical products across VA medical facilities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00005 | Exercise an Option | $0 | 9/9/25 | |
| P00004 | Exercise an Option | $0 | 11/5/24 | |
| P00003 | Supplemental Agreement for work within scope | $0 | 10/23/24 | |
| P00002 | Supplemental Agreement for work within scope | $0 | 4/8/24 | |
| P00001 | Supplemental Agreement for work within scope | $0 | 12/13/23 |
Name | Description | Awardee | Potential Value | AwardDate | CompletionDate | Updated At |
|---|---|---|---|---|---|---|
Delivery Order 36C10G24D0038-36C24225N0241 | Mimedx Group, Inc. | $10.4k | 11/8/24 | 12/31/24 | 11/8/24 | |
Delivery Order 36C10G24D0038-36C10G24N0024 | Mimedx Group, Inc. | $0 | 11/9/23 | 11/5/24 | 2/12/25 |
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
6515--Arthrex Inc. VA National Prosthetics Next Generation Multiple Award IDIQ | 36C10G23R0010 | Department of Veterans Affairs Headquarters | Award Notice 16/18 | 1/9/24, 5:03 PM | |
6515--Depuy Synthes Joint Reconstruction VA National Prothetics Next Generation Follow-on Multiple Award IDIQ | 36C10G23R0010 | Department of Veterans Affairs Headquarters | Award Notice 13/18 | 12/12/23, 12:47 PM | |
6515--Organogenesis Inc. VA National Prothetics Next Generation Follow-on Multiple Award IDIQ | 36C10G23R0010 | Department of Veterans Affairs Headquarters | Award Notice 2/18 | 10/3/23, 10:31 AM | |
6515--Endologix LLC VA National Prothetics Next Generation Follow-on Multiple Award IDIQ | 36C10G23R0010 | Department of Veterans Affairs Headquarters | Award Notice 4/18 | 10/3/23, 12:08 PM | |
6515--Encore Medical DBO Enovis Surgical VA National Prothetics Next Generation Follow-on Multiple Award IDIQ | 36C10G23R0010 | Department of Veterans Affairs Headquarters | Award Notice 5/18 | 10/3/23, 4:25 PM |